$GYHT Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in HALOZYME THERAPEUTICS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in HALOZYME THERAPEUTICS, INC.. Get notifications about new insider transactions in HALOZYME THERAPEUTICS, INC. for free.

Page:   < prev 1 2 3 4 5 6 ... 15 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 04 2020GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.0011,5590165,782154.2 K to 165.8 K (+7.49 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0055,48700
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF19.2119,910382,471439,657459.6 K to 439.7 K (-4.33 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0055,4870459,567404.1 K to 459.6 K (+13.73 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0023,11900
Feb 04 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF19.218,275158,96396,806105.1 K to 96.8 K (-7.87 %)
Feb 04 2020GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0023,1190105,08182 K to 105.1 K (+28.21 %)
Oct 01 2019GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commeric ...Option ExerciseM0.0020,216060,647
Oct 01 2019GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commeric ...Payment of ExerciseF15.466,990108,06513,22620.2 K to 13.2 K (-34.58 %)
Oct 01 2019GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commeric ...BuyM0.0020,216020,2160 to 20.2 K
Aug 05 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...SellS16.701,32822,17838,58439.9 K to 38.6 K (-3.33 %)
Jun 17 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.006,87500
Jun 17 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF15.733,40853,60881,96285.4 K to 82 K (-3.99 %)
Jun 17 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.006,875085,37078.5 K to 85.4 K (+8.76 %)
Jun 03 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Option ExerciseM0.002,04304,084
Jun 03 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Payment of ExerciseF14.7570610,41439,91240.6 K to 39.9 K (-1.74 %)
Jun 03 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...BuyM0.002,043040,61838.6 K to 40.6 K (+5.30 %)
May 03 2019GYHTHALOZYME THERAPEUT ...Posard Matthew L.DirectorGrantA0.0012,1730114,924102.8 K to 114.9 K (+11.85 %)
May 03 2019GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorGrantA0.0012,1730224,924212.8 K to 224.9 K (+5.72 %)
May 03 2019GYHTHALOZYME THERAPEUT ...Daly James MDirectorGrantA0.0012,173056,87344.7 K to 56.9 K (+27.23 %)
May 03 2019GYHTHALOZYME THERAPEUT ...Connaughton BernadetteDirectorGrantA0.0012,173017,9545.8 K to 18 K (+210.57 %)
Apr 15 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCOption ExerciseM0.006,87500
Apr 15 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCPayment of ExerciseF16.542,37739,31666,37368.8 K to 66.4 K (-3.46 %)
Apr 15 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCBuyM0.006,875068,75061.9 K to 68.8 K (+11.11 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Option ExerciseM0.003,88407,767
Feb 22 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Payment of ExerciseF16.811,34322,57638,57539.9 K to 38.6 K (-3.36 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...BuyM0.003,884039,91836 K to 39.9 K (+10.78 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCOption ExerciseM0.0011,392022,784
Feb 22 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCPayment of ExerciseF16.813,93966,21561,87565.8 K to 61.9 K (-5.99 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCBuyM0.0011,392065,81454.4 K to 65.8 K (+20.93 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0011,392022,784
Feb 22 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF16.813,93966,21578,49582.4 K to 78.5 K (-4.78 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0011,392082,43471 K to 82.4 K (+16.04 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0039,354078,708
Feb 22 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF16.8119,511327,980416,580436.1 K to 416.6 K (-4.47 %)
Feb 22 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0039,3540436,091396.7 K to 436.1 K (+9.92 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Option ExerciseM0.006,790020,370
Feb 15 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Payment of ExerciseF16.542,32238,40636,06738.4 K to 36.1 K (-6.05 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...BuyM0.006,790038,38931.6 K to 38.4 K (+21.49 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCOption ExerciseM0.007,809023,425
Feb 15 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCPayment of ExerciseF16.542,70044,65854,42257.1 K to 54.4 K (-4.73 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCBuyM0.007,809057,12249.3 K to 57.1 K (+15.84 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.007,809023,425
Feb 15 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF16.542,70044,65871,04273.7 K to 71 K (-3.66 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.007,809073,74265.9 K to 73.7 K (+11.84 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0028,730086,188
Feb 15 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF16.5414,244235,596396,737411 K to 396.7 K (-3.47 %)
Feb 15 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0028,7300410,981382.3 K to 411 K (+7.52 %)
Feb 14 2019GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commerci ...Option ExerciseA0.0037,538037,538
Feb 14 2019GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commerci ...Option ExerciseA16.6571,6021,192,17371,602
Feb 14 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Option ExerciseA0.0037,538037,538
Feb 14 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Option ExerciseA16.6571,6021,192,17371,602
Feb 14 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCOption ExerciseA0.0037,538037,538
Feb 14 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCOption ExerciseA16.6571,6021,192,17371,602
Feb 14 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA0.0045,046045,046
Feb 14 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA16.6585,9221,430,60185,922
Feb 14 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA0.00131,1790131,179
Feb 14 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA16.65250,2184,166,130250,218
Feb 06 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0031,25000
Feb 06 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF16.7314,547243,371382,251396.8 K to 382.3 K (-3.67 %)
Feb 06 2019GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0031,2500396,798365.5 K to 396.8 K (+8.55 %)
Feb 05 2019GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Payment of ExerciseF16.122,50340,34831,59934.1 K to 31.6 K (-7.34 %)
Feb 05 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCOption ExerciseM0.0015,413015,413
Feb 05 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCPayment of ExerciseF16.125,65891,20749,31355 K to 49.3 K (-10.29 %)
Feb 05 2019GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GCBuyM0.0015,413054,97139.6 K to 55 K (+38.96 %)
Feb 05 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0023,119023,119
Feb 05 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF16.128,317134,07065,93374.3 K to 65.9 K (-11.20 %)
Feb 05 2019GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0023,119074,25051.1 K to 74.3 K (+45.22 %)
Dec 10 2018GYHTHALOZYME THERAPEUT ...MATSUI CONNIEDirectorGiftG0.0015,0000227,751242.8 K to 227.8 K (-6.18 %)
Oct 03 2018GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commerci ...Option ExerciseA0.0080,863080,863
Oct 03 2018GYHTHALOZYME THERAPEUT ...Hickey BenjaminSVP, Chief Commerci ...Option ExerciseA18.55149,5162,773,522149,516
Sep 11 2018GYHTHALOZYME THERAPEUT ...Connaughton BernadetteDirectorGrantA0.005,78105,7810 to 5.8 K
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.02256,8604,628,6171,897,6102.2 M to 1.9 M (-11.92 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.2264,9961,184,2272,154,4702.2 M to 2.2 M (-2.93 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.2061,4281,117,9902,219,4662.3 M to 2.2 M (-2.69 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.02175,3893,160,5103,900,9194.1 M to 3.9 M (-4.30 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.2244,381808,6224,076,3084.1 M to 4.1 M (-1.08 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.2041,944763,3814,120,6894.2 M to 4.1 M (-1.01 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.48149,3532,760,0432,280,8942.4 M to 2.3 M (-6.15 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.49464,6248,126,2742,430,2472.9 M to 2.4 M (-16.05 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.1595,8191,643,2962,894,8713 M to 2.9 M (-3.20 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.48101,9821,884,6274,162,6334.3 M to 4.2 M (-2.39 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.49317,2575,548,8254,264,6154.6 M to 4.3 M (-6.92 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.1565,4271,122,0734,581,8724.6 M to 4.6 M (-1.41 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.2456,668976,9562,985,0543 M to 3 M (-1.86 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.1554,397932,9093,041,7223.1 M to 3 M (-1.76 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.36180,1543,127,4733,096,1193.3 M to 3.1 M (-5.50 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.2438,695667,1024,643,4514.7 M to 4.6 M (-0.83 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.1537,144637,0204,682,1464.7 M to 4.7 M (-0.79 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.36123,0142,135,5234,719,2904.8 M to 4.7 M (-2.54 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.08120,6062,059,9503,276,2733.4 M to 3.3 M (-3.55 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.48132,5912,317,6913,396,8793.5 M to 3.4 M (-3.76 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.5287,1851,527,4813,529,4703.6 M to 3.5 M (-2.41 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.0882,3531,406,5894,842,3044.9 M to 4.8 M (-1.67 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.4890,5361,582,5694,924,6575 M to 4.9 M (-1.81 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.5259,5331,043,0185,015,1935.1 M to 5 M (-1.17 %)
Aug 06 2018GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Payment of ExerciseF17.081,30522,28934,10235.4 K to 34.1 K (-3.69 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9029,074491,3513,616,6553.6 M to 3.6 M (-0.80 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3089,1361,542,0533,645,7293.7 M to 3.6 M (-2.39 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3261,7411,069,3543,734,8653.8 M to 3.7 M (-1.63 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9019,853335,5165,074,7265.1 M to 5.1 M (-0.39 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3060,8641,052,9475,094,5795.2 M to 5.1 M (-1.18 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3242,159730,1945,155,4435.2 M to 5.2 M (-0.81 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9772,7531,234,6183,796,6063.9 M to 3.8 M (-1.88 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9772,7531,234,6183,796,6063.9 M to 3.8 M (-1.88 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9976,2911,296,1843,869,3593.9 M to 3.9 M (-1.93 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9976,2911,296,1843,869,3593.9 M to 3.9 M (-1.93 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3431,795551,3253,945,6504 M to 3.9 M (-0.80 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3431,795551,3253,945,6504 M to 3.9 M (-0.80 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9749,678843,0365,197,6025.2 M to 5.2 M (-0.95 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9749,678843,0365,197,6025.2 M to 5.2 M (-0.95 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9952,094885,0775,247,2805.3 M to 5.2 M (-0.98 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9952,094885,0775,247,2805.3 M to 5.2 M (-0.98 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3421,710376,4515,299,3745.3 M to 5.3 M (-0.41 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3421,710376,4515,299,3745.3 M to 5.3 M (-0.41 %)
Jun 05 2018GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Option ExerciseM0.002,04306,127
Jun 05 2018GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...Payment of ExerciseF18.5971213,23635,40736.1 K to 35.4 K (-1.97 %)
Jun 05 2018GYHTHALOZYME THERAPEUT ...Chondros DimitriosSVP, Chief Medical ...BuyM0.002,043036,11934.1 K to 36.1 K (+6.00 %)
May 02 2018GYHTHALOZYME THERAPEUT ...Posard Matthew L.DirectorGrantA0.0010,3630102,75192.4 K to 102.8 K (+11.22 %)
May 02 2018GYHTHALOZYME THERAPEUT ...MATSUI CONNIEDirectorGrantA0.0010,3630242,751232.4 K to 242.8 K (+4.46 %)
May 02 2018GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorGrantA0.0010,3630212,751202.4 K to 212.8 K (+5.12 %)
May 02 2018GYHTHALOZYME THERAPEUT ...Henderson Jeffrey WilliamDirectorGrantA0.0010,363051,10540.7 K to 51.1 K (+25.44 %)
May 02 2018GYHTHALOZYME THERAPEUT ...Daly James MDirectorGrantA0.0010,363044,70034.3 K to 44.7 K (+30.18 %)
May 02 2018GYHTHALOZYME THERAPEUT ...BIZZARI JEAN-PIERREDirectorGrantA0.0010,363061,31250.9 K to 61.3 K (+20.34 %)
Apr 13 2018GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GC and CCOOption ExerciseM0.006,87506,875
Apr 13 2018GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GC and CCOPayment of ExerciseF19.372,37746,04239,55841.9 K to 39.6 K (-5.67 %)
Apr 13 2018GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GC and CCOBuyM0.006,875041,93535.1 K to 41.9 K (+19.61 %)
Feb 23 2018GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GC and CCOOption ExerciseM0.0011,392034,176
Feb 23 2018GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GC and CCOPayment of ExerciseF19.283,93975,94435,06039 K to 35.1 K (-10.10 %)
Feb 23 2018GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GC and CCOBuyM0.0011,392038,99927.6 K to 39 K (+41.26 %)
Feb 23 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0011,392034,176
Feb 23 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF19.283,93975,94447,51051.4 K to 47.5 K (-7.66 %)
Feb 23 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...BuyM0.0011,392051,44940.1 K to 51.4 K (+28.44 %)
Feb 23 2018GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0039,3540118,062
Feb 23 2018GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF19.2819,511376,172329,486349 K to 329.5 K (-5.59 %)
Feb 23 2018GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0039,3540348,997309.6 K to 349 K (+12.71 %)
Feb 16 2018GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GC and CCOOption ExerciseA0.0031,234031,234
Feb 16 2018GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GC and CCOOption ExerciseA18.4154,7801,008,50054,780
Feb 16 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA0.0031,234031,234
Feb 16 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseA18.4154,7801,008,50054,780
Feb 16 2018GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA0.00114,9180114,918
Feb 16 2018GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA18.41201,5523,710,572201,552
Feb 06 2018GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0031,250031,250
Feb 06 2018GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF18.2515,493282,747309,643325.1 K to 309.6 K (-4.77 %)
Feb 06 2018GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0031,2500325,136293.9 K to 325.1 K (+10.63 %)
Feb 05 2018GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GC and CCOOption ExerciseM0.0015,413030,826
Feb 05 2018GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GC and CCOPayment of ExerciseF18.375,605102,96427,60733.2 K to 27.6 K (-16.88 %)
Feb 05 2018GYHTHALOZYME THERAPEUT ...LEONHARDT HARRY JSVP, GC and CCOBuyM0.0015,413033,21217.8 K to 33.2 K (+86.59 %)
Feb 05 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Option ExerciseM0.0023,120046,238
Feb 05 2018GYHTHALOZYME THERAPEUT ...Stelzer LaurieSVP, Chief Financia ...Payment of ExerciseF18.378,265151,82840,05748.3 K to 40.1 K (-17.10 %)

Page:   < prev 1 2 3 4 5 6 ... 15 next >

Contact us | Follow us on Twitter